SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-May-14 9:48 PM View: | NuVasive, Inc. (NUVA) | 22-May-14 | Grant | 3,725 | -- | -- | 17% 22.5K to 26.22K | |
14-Nov-14 10:00 PM View: | NuVasive, Inc. (NUVA) | 22-May-14 | Option Exercise | 18,000 | $25.89 | $466,020.00 | 107% 16.83K to 34.83K | |
14-Nov-14 10:00 PM View: | NuVasive, Inc. (NUVA) | 22-May-14 | Private Option Sale | 18,000 | $43.60 | $784,831.00 | (52%) 34.83K to 16.83K | |
17-Mar-14 7:07 PM View: | NuVasive, Inc. (NUVA) | 13-Mar-14 | Option Exercise | 24,000 | $25.89 | $621,360.00 | 150% 16.0K to 40.0K | |
17-Mar-14 7:07 PM View: | NuVasive, Inc. (NUVA) | 11-Mar-14 | Market Option Sale | 24,000 | $37.13 | $891,240.00 | (60%) 40.0K to 16.0K | (58%) |
28-May-13 6:40 PM View: | NuVasive, Inc. (NUVA) | 23-May-13 | Grant | 2,833 | -- | -- | 100% 0 to 2.83K | |
25-May-12 5:29 PM View: | NuVasive, Inc. (NUVA) | 24-May-12 | Grant | 2,833 | -- | -- | 100% 0 to 2.83K | |
03-Nov-11 7:14 PM View: | NuVasive, Inc. (NUVA) | 02-Nov-11 | Market Purchase | 5,000 | $14.18 | $70,900.00 | 45% 11.0K to 16.0K | 313% |
26-Aug-11 6:17 PM View: | NuVasive, Inc. (NUVA) | 25-Aug-11 | Market Purchase | 4,000 | $21.25 | $85,000.00 | 57% 7.0K to 11.0K | 176% |
25-Jul-11 7:33 PM View: | NuVasive, Inc. (NUVA) | 22-Aug-11 | Grant | 833 | -- | -- | 100% 0 to 0.83K | |
18-Nov-10 5:25 PM View: | NuVasive, Inc. (NUVA) | 16-Nov-10 | Market Purchase | 2,000 | $24.25 | $48,500.00 | 40% 5.0K to 7.0K | 145% |
03-Dec-09 6:32 PM View: | NuVasive, Inc. (NUVA) | 01-Dec-09 | Market Purchase | 3,000 | $32.74 | $98,220.00 | 150% 2.0K to 5.0K | 82% |
09-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 05-Feb-04 | Disposition (change in control) | 31,185 | $35.00 | $1,091,480.00 | (100%) 31.18K to 0 | |
28-Aug-03 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 26-Aug-03 | Sale | 20,000 | $16.00 | $320,000.00 | (39%) 51.19K to 31.18K |